课题基金 / 基金详情

The role of phosphorylated NF-κB, p65 subunit on physiological and inflammatory responses

The role of phosphorylated NF-κB, p65 subunit on physiological and inflammatory responses
磷酸化 NF-κB、p65 亚基对生理和炎症反应的作用
批准号:
20592179
负责人:
MATSUO Kou
金额:
$3.0万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2008
资助国家:
日本
项目状态:
已结题
起止时间:
2008 至 2010

项目摘要

项目成果

MATSUO Kou的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The transcription factor NF-κB regulates the expression of a wide range of genes, including various proinflammatory cytokines, cell adhesion proteins, and several anti-apoptotic molecules that together play pivotal roles in almost all aspects of immune and inflammatory responses. In resting cells, NF-κB associates with members of the inhibitory family of IκB proteins, resulting in retention of these complexes in the cytoplasm. Following appropriate stimulation, IκB proteins are phosphorylated on two specific NH_2-terminal serine residues by one of the catalytic subunits of the IκB kinase (IKK). Phosphorylated IκBs are subsequently ubiquitinated and degraded by the proteasome, leaving NF-κB free to translocate to the nucleus, where it binds to cognate enhancer/promoter elements in its cohort of target genes. However, we and others have shown that, besides the regulated degradation of IκBs, phosphorylation of nuclear NF-κB p65 is also an obligatory step for efficient transcription of NF- … More κB-dependent genes. Several different protein kinases and putative sites of phosphorylation on p65 have been identified, and, in general, it is believed that these phosphorylation events occur concomitantly with IKK-mediated phosphorylation of IκB proteins. We suggest that this additional step in the NF-κB activation pathway helps ensure that only NF-κB that enters the nucleus from the cytoplasm in response to appropriate inducing signals is able to trigger gene expression.To address the biological importance of the putative sites of phosphorylation on p65, Ser 276 and Ser 534, we generated knock-in mice expressing a serine-to-alanine mutation. Instead of the expected embryonic lethality from hepatocyte apoptosis seen in the absence of NF-κB activity, the S276A knock-in embryos die at different embryonic days due to variegated developmental abnormalities. We demonstrate that this variegated phenotype is due to epigenetic repression resulting from the recruitment of histone deacetylases by the nonphosphorylatable form of NF-κB into the vicinity of genes positioned fortuitously near NF-κB-binding sites. Therefore, unphosphorylated nuclear NF-κB can affect expression of genes not normally regulated by NF-κB through epigenetic mechanisms. On the other hand, S534A knock-in mice demonstrated normal development with slight increasing body weight. Consistent with these results, we observed increased subcutaneous fat in S534A mice compared with control littermate.To further determine whether changing the Ser 276 to a phospyhomimetic amino acid could mimic phosphorylation, and to examine the biological consequences of such a modification, we knocked in a mutant form of p65, where Ser 276 was changed to aspartic acid (S276D), into the genome. Mice bearing the p65 S276D mutation are born at normal Mendelian ratios, but soon begin to display a progressive, systemic hyperinflammatory condition that results in severe runting and, typically, death 8-20 d after birth. We demonstrated that a significant number of NF-κB target genes are up-regulated in these mice, thereby explaining the hyperinflammatory phenotype. Remarkably, crossing the knock-in strain with mice lacking TNF receptor 1 (TNFR1) leads to a complete rescue of the systemic inflammatory phenotype, but not in certain local inflammatory conditions-including one that resembles human keratoconjunctivitis sicca (KCS) or "dry eye". Therefore, the p65 S276D knock-in mice provide a unique model system, demonstrating the distinct roles of NF-κB in systemic inflammation and certain localized inflammatory diseases. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Promoting effects of thymosin.4 on granulation tissue and new bone formation after extraction in rats.
胸腺肽4对大鼠拔牙后肉芽组织和新骨形成的促进作用。
DOI: --
发表时间: 2011
期刊: Oral Surg Oral Med Oral Pathol Oral Radiol Endod (accepted)
影响因子: --
作者: [Matsuo K, Akasaki Y, Adachi K, Zhang M, Ishikawa A, Jimi E, Nishihara T, Hosokawa R.]
通讯作者: Hosokawa R.
Regulation of gene expression by phosphorylated NF-.B, p65
磷酸化 NF-.B、p65 对基因表达的调节
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [N.Yonehara, M.Takemura (7人中5番目), Jimi E]
通讯作者: Jimi E
DOI: 10.1371/journal.pone.0012554
发表时间: 2010-09-03
期刊: PloS one
影响因子: 3.7
作者: [Yamamoto D, Shima K, Matsuo K, Nishioka T, Chen CY, Hu GF, Sasaki A, Tsuji T]
通讯作者: Tsuji T
-thymosinsの歯科口腔外科治療応用に向けた基礎的研究
-胸腺肽在牙科和口腔外科治疗中应用的基础研究
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [A.Yano, S.Kikuchi, Y.Yamashita, Y.Sakamoto, Y.Nakagawa, Y.Yoshida, 松尾拡]
通讯作者: 松尾拡
12
    Establishment of bone invasion model by oral cancer and effects of NF-kB inhibitor on bone invasion.
    • 批准号:
      23592707
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.33万
    • 财政年份:
      2011
    • 负责人:
      MATSUO Kou
    • 依托单位:
    Functional Analyses of new genes involved in tooth germ development
    Mutational changes of EGFR mRNA in oral cancers and functions of a candidate tumor suppressor, doc-1
    • 批准号:
      10470384
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $8.38万
    • 财政年份:
      1998
    • 负责人:
      MATSUO Kou
    • 依托单位:
    国内基金
    海外基金
    苏木酮A介导NLRX1调控TRAF6/NF-κB抑制破骨细胞分化缓解骨质疏松症的机制研究
    • 批准号:
      2026JJ82705
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘中
    • 依托单位:
    贝母素乙通过激活NF-κB信号通路调控线粒体功能障碍介导三阴型乳腺癌细胞焦亡的作用机制研究
    • 批准号:
      2026JJ80203
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      易念
    • 依托单位:
    嗜黏蛋白阿克曼菌通过AMPK/SIRT1/NF-κB信号通路调节非酒精性脂肪肝的机制研究
    • 批准号:
      2026JJ80624
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      李昌敏
    • 依托单位:
    丁酸梭菌分泌的丁酸通过TLR4/NF-κB信号通路调控ICCs介导ICH后胃肠动力的机制研究
    • 批准号:
      2026JJ80329
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘艳辉
    • 依托单位: